BTI Share Price

Open 0.75 Change Price %
High 0.80 1 Day 0.07 9.59
Low 0.74 1 Week 0.03 3.90
Close 0.80 1 Month -0.13 -13.98
Volume 107900 1 Year -0.60 -42.86
52 Week High 2.05
52 Week Low 0.66
BTI Important Levels
Resistance 2 0.86
Resistance 1 0.83
Pivot 0.78
Support 1 0.77
Support 2 0.74
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
AZU 0.02 100.00%
AZU 0.02 100.00%
NMG 0.02 100.00%
NMG 0.02 100.00%
SSA 0.02 100.00%
ELT 0.02 100.00%
ELT 0.02 100.00%
DDX 0.50 100.00%
CPC 0.02 100.00%
CMV 0.02 100.00%
More..
CVE Canada Top Losers Stocks
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
LAK 0.02 -33.33%
SDS 0.02 -33.33%
More..

biOasis Technologies Inc (CVE: BTI)

BTI Technical Analysis 4
As on 24th Mar 2017 BTI Share Price closed @ 0.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.30 & Sell for SHORT-TERM with Stoploss of 0.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
BTI Target for March
1st Target up-side 1.05
2nd Target up-side 1.12
3rd Target up-side 1.19
1st Target down-side 0.85
2nd Target down-side 0.78
3rd Target down-side 0.71
BTI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioasis.ca
BTI Address
BTI
1385 West 8th Avenue
Suite 600
Vancouver, BC V6H 3V9
Canada
Phone: 778-383-3280
Fax: 604-215-0091
BTI Latest News
Research Reports Initiated on Healthcare Stocks Cardiome Pharma, ProMetic Life ...   Yahoo Finance   - 16th Mar 17
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H1 2017 ...   Business Wire (press release)   - 15th Mar 17
biOasis Enters Into a License Agreement With Vaccinex Inc.   Marketwired (press release)   - 21st Sep 16
Research Reports Initiated on Biotech Stocks Emerald Health Therapeutics ...   Baystreet.ca   - 29th Aug 16
Podcast: biOasis Technologies Inc CEO Rob Hutchison on how his company is ...   Financial Post   - 29th Mar 16
Three S&P TSX Venture Exchange health sciences companies worth watching   Financial Post   - 28th Mar 16
bioMmune Technologies Inc. Announces Appointment of Directors   Marketwired (press release)   - 09th Dec 15
Monday Deal Review - November 3, 2015   Proactive Investors USA & Canada (blog)   - 04th Nov 15
biOasis Engages Willow Tree Group to Assist with Global Business Development ...   Marketwired (press release)   - 07th Oct 14
biOasis Delivers siRNA Across the Blood-Brain Barrier   Drug Discovery & Development   - 08th May 14
Interactive Technical Analysis Chart biOasis Technologies Inc ( BTI CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on biOasis Technologies Inc
BTI Business Profile
biOasis Technologies Inc., an early stage biopharmaceutical company, engages in the research, development, and commercialization of technologies and products for the diagnosis and treatment of central nervous system diseases and disorders. The company develops Transcend program, a protein vector, which is a proprietary carrier for the transport of therapeutic agents across the blood brain barrier for treatment of a range of neurological, oncological, and infectious disease applications; and Cognitest, a proprietary in vitro diagnostic assay for Alzheimer’s disease. It has a collaborative research agreement with the University of British Columbia to assist the company in development of an enzyme linked immunosorbent assay to detect levels of p97 in blood for the purpose of evaluating the correlation between p97 and Alzheimer’s disease. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.